Point of Care Diagnostics (POC) Market Size, Market Share, Application Analysis, Regional Outlook, Growth, Trends, Competitive Scenario And Forecasts, 2012 To 2020: Hexa Research
The increasing market penetration of picture archiving and communication systems (PACS) and electronic medical record (EMR) and the efficiency of point of care diagnostics to provide immediate results are the major factors driving the global point of care diagnostics market. In point of care (POC) diagnosis, the tests are conducted near the site of the patient care. The increasing geriatric population globally is also a factor propelling the point of care (POC) diagnostics market. Moreover, increasing usage of home based point of care devices, increasing government support, expansion of therapeutic horizon and rapidly increasing investments by various healthcare institutes to support new product developments are also the factors driving the point of care diagnostics market. There is a shortage of skilled staff, especially in the field of diagnostics. Various government initiatives to innovate out patient care models and to minimize hospital stays and rapidly increasing demand for home healthcare globally are the factors expected to further fuel the point of care diagnostics market over the forecast period.
Browse Point of Care Diagnostics (POC) Market Report with Full TOC at: http://www.hexaresearch.com/research-report/point-of-care-diagnostics-poc-market-size-marketshare-application-analysis-regional-outlook-growth-trends-competitive-scenario-and-forecasts-2012to-2020/
The global point of care diagnostics market on the basis of product is segmented into urinalysis, fertility and feces, drug abuse testing, decentralized clinical chemistry, primary care systems (lipid and Hba1C), coagulation, hematology, cardiac markers, dedicated professional hospital glues testing, infectious diseases and blood gas/ electrolytes.
Table of Contents: Chapter 1. Executive Summary 1.1. Point of Care Diagnostics – Industry Summary and Critical Success Factors (CSFs) Chapter 2. Point of Care Diagnostics Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Point of Care Diagnostics Market Dynamics 2.4. Key Opportunities Prioritized 2.5. Industry Analysis – Porter’s 2.6. Point of Care Diagnostics – Company Market Share Analysis 2.7. Point of Care Diagnostics Market PESTEL Analysis, 2012 Chapter 3. Point of Care Diagnostics Product Outlook 3.1. Blood Gas/Electrolytes (Centralized and Decentralized) 3.2. Infectious Diseases 3.3. Hospital Glucose Testing 3.4. Cardiac Markers 3.5. Hematology 3.6. Coagulation 3.7. Primary Care Systems (Lipid Profiling and HbA1c Tests)
3.8. Decentralized Clinical Chemistry 3.9. Urinalysis 3.10. Drug Abuse Testing 3.11. Fertility 3.12. OTC and Rapid Diagnostic Tests Chapter 4. Point of Care Diagnostics End User Outlook 4.1. Hospitals 4.2. Assisted Living Healthcare Facilities 4.3. Laboratories 4.4. Home 4.5. Clinics 4.6. Others Chapter 5. Point of Care Diagnostics Regional Outlook 5.1. North America 5.2. Europe 5.3. Asia Pacific 5.4. RoW Chapter 6. Point of Care Diagnostics Competitive landscape 6.1. Roche Diagnostics 6.1.1 Company Overview
6.1.2 Financial Performance 6.1.3 Product Benchmarking 6.1.4 Strategic Initiatives
6.2 Abbott Laboratories 6.2.1 Company Overview 6.2.2 Financial Performance 6.2.3 Product Benchmarking 6.2.4 Strategic Initiatives
6.3 Siemens Healthcare 6.3.1 Company Overview 6.3.2 Financial Performance 6.3.3 Product Benchmarking 6.3.4 Strategic Initiatives
6.4 Beckman Coulter Inc. 6.4.1 Company Overview 6.4.2 Financial Performance 6.4.3 Product Benchmarking 6.4.4 Strategic Initiatives
6.5 Becton Dickinson and Company 6.5.1 Company Overview 6.5.2 Financial Performance 6.5.3 Product Benchmarking 6.5.4 Strategic Initiatives
6.6 bioMĂŠrieux 6.6.1 Company Overview 6.6.2 Financial Performance
6.6.3 Product Benchmarking 6.6.4 Strategic Initiatives
6.7 Johnson and Johnson 6.7.1 Company Overview 6.7.2 Financial Performance 6.7.3 Product Benchmarking 6.7.4 Strategic Initiatives
6.8 Abaxis Inc. 6.8.1 Company Overview 6.8.2 Financial Performance 6.8.3 Product Benchmarking 6.8.4 Strategic Initiatives
6.9 Alere Inc. 6.9.1 Company Overview 6.9.2 Financial Performance 6.9.3 Product Benchmarking 6.9.4 Strategic Initiatives
6.10 Danaher Corporation 6.10.1 Company Overview 6.10.2 Financial Performance 6.10.3 Product Benchmarking 6.10.4 Strategic Initiatives
6.11 Qiagen (AmniSure)
6.11.1 Company Overview 6.11.2 Financial Performance 6.11.3 Product Benchmarking 6.11.4 Strategic Initiatives
6.12 Spectral Diagnostics 6.12.1 Company Overview 6.12.2 Financial Performance 6.12.3 Product Benchmarking 6.12.4 Strategic Initiatives
6.13 Church & Dwight Co. Inc. 6.13.1 Company Overview 6.13.2 Financial Performance 6.13.3 Product Benchmarking 6.13.4 Strategic Initiatives
6.14 Trinity Biotech PLC 6.14.1 Company Overview 6.14.2 Financial Performance 6.14.3 Product Benchmarking 6.14.4 Strategic Initiatives
6.15 Nipro Diagnostics Inc. 6.15.1 Company Overview 6.15.2 Financial Performance 6.15.3 Product Benchmarking 6.15.4 Strategic Initiatives
6.16 Hemocue AB 6.16.1 Company Overview 6.16.2 Financial Performance 6.16.3 Product Benchmarking 6.16.4 Strategic Initiatives
6.17 Nova Biomedical 6.17.1 Company Overview 6.17.2 Financial Performance 6.17.3 Product Benchmarking 6.17.4 Strategic Initiatives
6.18 Pharmatech Inc. 6.18.1 Company Overview 6.18.2 Financial Performance 6.18.3 Product Benchmarking 6.18.4 Strategic Initiatives
6.19 International Technidyne Corporation (ITC) 6.19.1 Company Overview 6.19.2 Financial Performance 6.19.3 Product Benchmarking 6.19.4 Strategic Initiatives
6.20 Quidel Corporation 6.20.1 Company Overview 6.20.2 Financial Performance
6.20.3 Product Benchmarking 6.20.4 Strategic Initiatives
6.21 Sekisui Diagnostics 6.21.1 Company Overview 6.21.2 Financial Performance 6.21.3 Product Benchmarking 6.21.4 Strategic Initiatives
6.22 OraSure Technologies Inc. 6.22.1 Company Overview 6.22.2 Financial Performance 6.22.3 Product Benchmarking 6.22.4 Strategic Initiatives Chapter 7. Methodology and Scope 7.1. Research Methodology 7.2. Research Scope & Assumption 7.3. List of Data Sources
Browse More Details @ http://www.hexaresearch.com/research-report/point-of-care-diagnosticspoc-market-size-market-share-application-analysis-regional-outlook-growth-trends-competitivescenario-and-forecasts-2012-to-2020/
List of Tables:
Point of Care Diagnostics – Industry Summary & Critical Success Factors (CSFs)
Global Point of Care Diagnostics Revenue, 2012 – 2020
Global Point of Care Diagnostics Market Revenue by Region, (USD million), 2012 – 2020
Global Point of Care Diagnostics Market Revenue by Segments, (USD million), 2012 – 2020
Global Point of Care Diagnostics Market Revenue by End-Users (USD million), 2012 – 2020
Global point of care diagnostics demand, by hospitals, 2012 to 2020 (USD million)
Global point of care diagnostics hospital demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by laboratory, 2012 to 2020 (USD million)
Global point of care diagnostics laboratory demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by assisted living healthcare facilities, 2012 to 2020 (USD million)
Global point of care diagnostics assisted living healthcare facilities demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by home, 2012 to 2020 (USD million)
Global point of care diagnostics home demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by clinics, 2012 to 2020 (USD million)
Global point of care diagnostics clinics demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by other facilities, 2012 to 2020 (USD million)
Global point of care diagnostics other facilities demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by blood gas/electrolytes, 2012 to 2020 (USD million)
Global point of care diagnostics for blood gas/electrolytes demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by infectious diseases, 2012 to 2020 (USD million)
Global point of care diagnostics for infectious disease demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by glucose testing, 2012 to 2020 (USD million)
Global point of care diagnostics for glucose testing demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by cardiac markers, 2012 to 2020 (USD million)
Global point of care diagnostics for cardiac markers demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by hematology, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by hematology, 2012 to 2020 (USD million)
Global point of care diagnostics for hematology demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by coagulation, 2012 to 2020 (USD million)
Global point of care diagnostics for coagulation demand, by region, 2012 to 2020 (USD million)
Global wet point of care diagnostic tests for hematology demand, by region, 2012 to 2020 (USD million)
Global wet point of care diagnostic tests for hematology demand, by end-users, 2012 to 2020 (USD million)
Global dry point of care diagnostic tests for hematology demand, by region, 2012 to 2020 (USD million)
Global dry point of care diagnostic tests for hematology demand, by end-users, 2012 to 2020 (USD million)
North America point of care diagnostics demand, by products, (USD million), 2012 – 2020
North America point of care diagnostics demand, by end-users, (USD million), 2012 – 2020
Europe point of care diagnostics demand, by products, (USD million), 2012 – 2020
Europe point of care diagnostics demand, by end-users, (USD million), 2012 – 2020
Asia Pacific point of care diagnostics demand, by products, (USD million), 2012 – 2020
Asia Pacific point of care diagnostics demand, by end-users, (USD million), 2012 – 2020
RoW point of care diagnostics demand, by products, (USD million), 2012 – 2020
RoW point of care diagnostics demand, by end-users, (USD million), 2012 – 2020
Global Point of Care Diagnostics Market – Competitive Landscape
List of Figures:
Point of Care Diagnostics Market Segmentation
Global Point of Care Diagnostics Market Revenue, 2012 – 2020
Point of Care Diagnostics Market Dynamics
Global population base over the age group of 60 years, 2010 and 2017 (million)
Global diabetes prevalence, 2010 and 2017 (million)
Point Of Care Diagnostics Company Market Share Analysis, 2012
Key Opportunities Prioritized
Industry Analysis – Porter’s
Point of Care Diagnostics PESTEL Analysis, 2012
Global point of care diagnostics revenue, by end-users, 2012 & 2020
Global point of care diagnostics demand, by hospitals, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by laboratory, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by assisted living, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by home, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by clinics, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by others, 2012 to 2020 (USD million)
Global point of care diagnostics revenue, by products, 2012 & 2020
Global blood gas/electrolytes demand, by region, 2012 to 2020 (USD million)
Global infectious diseases demand, by region, 2012 to 2020 (USD million)
Global professional hospital glucose testing demand, by region, 2012 to 2020 (USD million)
Global cardiac markers demand, by region, 2012 to 2020 (USD million)
Global hematology demand, by region, 2012 to 2020 (USD million)
Global coagulation demand, by region, 2012 to 2020 (USD million)
Global primary care systems demand, by region, 2012 to 2020 (USD million)
Global decentralized clinical chemistry demand, by region, 2012 to 2020 (USD million)
Global urinalysis demand, by region, 2012 to 2020 (USD million)
Global drug abuse testing demand, by region, 2012 to 2020 (USD million)
Global fertility demand, by region, 2012 to 2020 (USD million)
Global feces demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics for hematology revenue, by products, 2012 & 2020
Global wet hematology tests demand, by region, 2012 to 2020 (USD million)
Global wet hematology tests demand, by end-users, 2012 to 2020 (USD million)
Global dry hematology tests demand, by region, 2012 to 2020 (USD million)
Global dry hematology tests demand, by end-users, 2012 to 2020 (USD million)
Point of care diagnostics market – company market share analysis, 2012 (%)
Get More Information And Request For Sample Report With Full TOC @ http://www.hexaresearch.com/research-report/point-of-care-diagnostics-poc-market-size-marketshare-application-analysis-regional-outlook-growth-trends-competitive-scenario-and-forecasts-2012to-2020/
ABOUT Hexa Research Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Contact: Michelle Thoras Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Web: http://www.hexaresearch.com/